Considerations in parathyroid hormone testing

被引:25
作者
Cavalier, Etienne [1 ]
Plebani, Mario [2 ]
Delanaye, Pierre [3 ]
Souberbielle, Jean-Claude [4 ]
机构
[1] Univ Liege, CHU Sart Tilman, Dept Clin Chem, B-4000 Liege, Belgium
[2] Univ Hosp Padua, Dept Lab Med, Padua, Italy
[3] Univ Liege, CHU Sart Tilman, Dept Nephrol Dialysis & Transplantat, B-4000 Liege, Belgium
[4] Hop Necker Enfants Malad, Lab Explorat Fonctionnelles, Paris, France
关键词
calcium metabolism; clinical guidelines; diurnal and seasonal rhythms; parathyroid hormone; reference ranges; sample of choice; stability; BONE-MINERAL METABOLISM; VITAMIN-D STATUS; PRIMARY HYPERPARATHYROIDISM; STORAGE-CONDITIONS; PTH CONCENTRATIONS; DIALYSIS PATIENTS; SERUM; STABILITY; HEMODIALYSIS; VARIABILITY;
D O I
10.1515/cclm-2015-0314
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Parathyroid hormone (PTH) is a major player in phosphocalcic metabolism and its measurement is very important for the correct diagnosis and treatment of several diseases. PTH determination represents the paradigm of quality in laboratory medicine as many variables in the pre-, intra-, and post-analytical phases strongly affect the value of the clinical information. Analytical determination of PTH has been rendered difficult by the presence, in the circulation, of truncated fragments that can cross-react with the antibodies used for its determination. In addition, pre-analytical phase is complicated by the lack of stability of the peptide and the best sample to use for its determination remains controversial, as well as sample handling and storage. PTH secretion is also affected by circadian and seasonal rhythms and by physical exercise. Finally, from the post-analytical perspective, establishment of reliable reference ranges requires further efforts as the selection criteria for reference subjects should take into consideration new variables such as gender, race and vitamin D levels. Finally, clinical guidelines have recently revised and improved the criteria for a correct interpretation of PTH values.
引用
收藏
页码:1913 / 1919
页数:7
相关论文
共 55 条
[1]
Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease [J].
Almond, Alison ;
Ellis, Andrew R. ;
Walker, Simon W. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :63-67
[2]
[Anonymous], 1994, 57256 ISO
[3]
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop [J].
Bilezikian, John P. ;
Brandi, Maria Luisa ;
Eastell, Richard ;
Silverberg, Shonni J. ;
Udelsman, Robert ;
Marcocci, Claudio ;
Potts, John T., Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) :3561-3569
[4]
Circulating forms of parathyroid hormone: Peeling back the onion [J].
Bringhurst, FR .
CLINICAL CHEMISTRY, 2003, 49 (12) :1973-1975
[5]
High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism [J].
Caron, Philippe ;
Maiza, Jean Christophe ;
Renaud, Claire ;
Cormier, Catherine ;
Barres, Beatrice Herbault ;
Souberbielle, Jean Claude .
CLINICAL ENDOCRINOLOGY, 2009, 70 (04) :533-538
[6]
Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients [J].
Cavalier, Etienne ;
Souberbielle, Jean-Claude ;
Gadisseur, Romy ;
Dubois, Bernard ;
Krzesinski, Jean-Marie ;
Delanaye, Pierre .
CLINICAL BIOCHEMISTRY, 2014, 47 (13-14) :1227-1230
[7]
Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations [J].
Cavalier, Etienne ;
Delanaye, Pierre ;
Lukas, Pierre ;
Carlisi, Agnes ;
Gadisseur, Romy ;
Souberbielle, Jean-Claude .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (08) :1137-1141
[8]
Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making [J].
Cavalier, Etienne ;
Delanaye, Pierre ;
Moranne, Olivier .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (05) :847-848
[9]
Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values [J].
Cavalier, Etienne ;
Delanaye, Pierre ;
Vranken, Laura ;
Bekaert, Anne-Catherine ;
Carlisi, Agnes ;
Chapelle, Jean-Paul ;
Souberbielle, Jean-Claude .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) :1950-1956
[10]
New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay [J].
Cavalier, Etienne ;
Carlisi, Agnes ;
Bekaert, Anne-Catherine ;
Rousselle, Olivier ;
Chapelle, Jean-Paul .
CLINICA CHIMICA ACTA, 2012, 413 (1-2) :353-354